Emer Clarke

674 total citations
14 papers, 510 citations indexed

About

Emer Clarke is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Emer Clarke has authored 14 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in Emer Clarke's work include Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Emer Clarke is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Acute Myeloid Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Emer Clarke collaborates with scholars based in United Kingdom, United States and Australia. Emer Clarke's co-authors include Jochen Guck, Róbert Langer, Krystyn J. Van Vliet, Franziska Lautenschläger, Dessy Nikova, John M. Maloney, Linda Hunt, Derwood Pamphilon, Jacqueline Cornish and Ann Green and has published in prestigious journals such as Blood, Biophysical Journal and Frontiers in Medicine.

In The Last Decade

Emer Clarke

13 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emer Clarke United Kingdom 9 247 186 105 97 90 14 510
Hye Na Kim United States 8 107 0.4× 94 0.5× 25 0.2× 119 1.2× 75 0.8× 20 307
Janet Fisher United Kingdom 10 116 0.5× 52 0.3× 37 0.4× 326 3.4× 170 1.9× 16 518
N. Monai Switzerland 5 220 0.9× 31 0.2× 85 0.8× 166 1.7× 91 1.0× 6 527
Thelma R. Tennant United States 8 228 0.9× 53 0.3× 28 0.3× 229 2.4× 75 0.8× 12 460
Tove Flem Jacobsen United States 12 156 0.6× 86 0.5× 11 0.1× 144 1.5× 42 0.5× 28 410
Ian Durrant United Kingdom 9 691 2.8× 774 4.2× 41 0.4× 189 1.9× 305 3.4× 23 1.2k
Elena Chklovskaia Switzerland 8 146 0.6× 12 0.1× 39 0.4× 207 2.1× 76 0.8× 12 497
David Cook United Kingdom 9 85 0.3× 17 0.1× 19 0.2× 126 1.3× 45 0.5× 13 362
Luca Trentin Italy 15 178 0.7× 154 0.8× 11 0.1× 381 3.9× 81 0.9× 25 556
Sarah Fong United States 7 380 1.5× 24 0.1× 23 0.2× 231 2.4× 72 0.8× 11 813

Countries citing papers authored by Emer Clarke

Since Specialization
Citations

This map shows the geographic impact of Emer Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emer Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emer Clarke more than expected).

Fields of papers citing papers by Emer Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emer Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emer Clarke. The network helps show where Emer Clarke may publish in the future.

Co-authorship network of co-authors of Emer Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Emer Clarke. A scholar is included among the top collaborators of Emer Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emer Clarke. Emer Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Belcher, John D., Fuad Abdulla, Ping Zhang, et al.. (2023). The BACH1 inhibitor ASP8731 inhibits inflammation and vaso-occlusion and induces fetal hemoglobin in sickle cell disease. Frontiers in Medicine. 10. 1101501–1101501. 14 indexed citations
2.
Singh, Maneet, Margaret Biddle, Emer Clarke, et al.. (2021). ML-0207/ASP8731: A Novel BACH1 Inhibitor That Induces Fetal Hemoglobin in Treatment of Sickle Cell Disease. Blood. 138(Supplement 1). 854–854. 5 indexed citations
3.
Davies, David L., et al.. (2016). Climb Every Mountain! Conquering Queensland’s ‘cliff’ Year through Learning Innovation. Literacy Information and Computer Education Journal. 7(1). 2180–2197. 1 indexed citations
4.
Tarrant, Jacqueline M., Preeti Dhawan, Jatinder Singh, et al.. (2015). Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid. Toxicology Mechanisms and Methods. 25(3). 201–211. 23 indexed citations
6.
Maloney, John M., Dessy Nikova, Franziska Lautenschläger, et al.. (2010). Mesenchymal Stem Cell Mechanics from the Attached to the Suspended State. Biophysical Journal. 99(8). 2479–2487. 136 indexed citations
7.
Pereira, Carla, et al.. (2007). Hematopoietic Colony-Forming Cell Assays. Methods in molecular biology. 407. 177–208. 31 indexed citations
8.
Clarke, Emer. (2004). Culture of Human and Mouse Mesenchymal Cells. Humana Press eBooks. 290. 173–186. 4 indexed citations
13.
Clarke, Emer, Glenn C. Rice, Reitha S. Weeks, et al.. (1996). Lisofylline inhibits transforming growth factor beta release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice.. PubMed. 56(1). 105–12. 27 indexed citations
14.
Clarke, Emer, et al.. (1990). Assessment of variables contributing to Cyclosporine distribution in blood. Irish Journal of Medical Science (1971 -). 159(9-12). 269–271.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026